Ignite Creation Date:
2025-12-24 @ 9:41 PM
Ignite Modification Date:
2025-12-29 @ 1:47 AM
Study NCT ID:
NCT05284032
Status:
TERMINATED
Last Update Posted:
2024-07-31
First Post:
2022-03-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Pilot Trial Using Isatuximab to Overcome Platelet Transfusion Refractoriness in Human Leukocyte Antigen Allo-Immunized Patients (SuppCare 001)
Sponsor:
Firas El Chaer, MD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-11-29
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-06-11
Completion Date Type:
ACTUAL
First Submit Date:
2022-03-08
First Submit QC Date:
None
Study First Post Date:
2022-03-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-29
Last Update Post Date:
2024-07-31
Last Update Post Date Type:
ACTUAL